China

A China biotech unicorn scores big with $150M-plus IPO on Nasdaq, stock rockets up
A China biotech unicorn scores big with $150M-plus IPO on Nasdaq, stock rockets up
Endpoints
China
biotech
IPOs
NASDAQ
Zai Labs
Flag link:
FDA Warns Korean, Chinese Drugmakers
FDA Warns Korean, Chinese Drugmakers
RAPS.org
FDA
warnings
China
Korea
drug manufacturing
Flag link:
3SBio snaps up Therapure CDMO for $290M
3SBio snaps up Therapure CDMO for $290M
BioPharma Dive
3SBio
Therapure
CDMOs
China
R&D
drug development
Flag link:
OrbiMed lines up $551M gamble on China, India biotech sectors
OrbiMed lines up $551M gamble on China, India biotech sectors
Endpoints
OrbiMed
China
India
biotech
venture capital
Flag link:
China wants to dominate medtech: Here’s how
China wants to dominate medtech: Here’s how
Mass Device
China
devices
Flag link:
Report: Chinese medical device market growing faster than pharma
Report: Chinese medical device market growing faster than pharma
Mass Device
China
devices
Flag link:
Medivir out-licenses hep C drug to China’s Ascletis; Cellectis launches pioneering UCART123 US study
Medivir out-licenses hep C drug to China’s Ascletis; Cellectis launches pioneering UCART123 US study
Endpoints
Medvir
hepatitis C
China
Ascletis
Cellectis
UCART123
CAR-T
Flag link:
Celgene-partnered Antengene preps new China deals as $21M round lands
Celgene-partnered Antengene preps new China deals as $21M round lands
Endpoints
Celgene
Antengene
China
Flag link:
10 Reasons Illumina's Momentum Is Just Cranking Up
10 Reasons Illumina's Momentum Is Just Cranking Up
Motley Fool
Illumina
NovaSeq
HiSeq
China
Helix
Flag link:
Sarepta to collaborate with Genethon on DMD gene therapy; Chinese investors pull back on Pluristem investment
Sarepta to collaborate with Genethon on DMD gene therapy; Chinese investors pull back on Pluristem investment
Endpoints
Sarepta Therapeutics
Genethon
Duchenne Muscular Dystrophy
gene therapy
China
Pluristem
Flag link:
FDA lifts warning letter on Zimmer Biomet plant in China
FDA lifts warning letter on Zimmer Biomet plant in China
Mass Device
FDA
warnings
Zimmer Biomet
devices
China
Flag link:
New Chinese VC leads $10M round for a Harvard spinout looking to industrialize platelet manufacturing
New Chinese VC leads $10M round for a Harvard spinout looking to industrialize platelet manufacturing
Endpoints
China
venture capital
Platelet BioGenesis
platelet manufacturing
Flag link:
Boehringer Ingelheim opens large manufacturing facility in China
Boehringer Ingelheim opens large manufacturing facility in China
BioPharma Dive
Boehringer Ingelheim
China
drug manufacturing
Flag link:
Chinese Regulators Set Procedures for Medical Device Expert Panel Meetings
Chinese Regulators Set Procedures for Medical Device Expert Panel Meetings
Emergo
China
devices
Flag link:
Bristol-Myers wins approval in China for oral treatment for chronic hepatitis C virus
Bristol-Myers wins approval in China for oral treatment for chronic hepatitis C virus
Marketwatch
Bristol-Myers Squibb
China
hepatitis C
Daklinza
Flag link:
China pharma poised for explosive growth, Novartis CEO says
China pharma poised for explosive growth, Novartis CEO says
Fierce Pharma
China
Novartis
Pharma CEOs
Joe Jimenez
Flag link:
How US Drugmakers Profit From China's Biotech Boom
How US Drugmakers Profit From China's Biotech Boom
Investopedia
China
biotech
Merck
Eli Lilly
Tesaro
Flag link:
China FDA getting rid of medical device testing fees
China FDA getting rid of medical device testing fees
Mass Device
China
FDA
devices
Flag link:
New guidelines to make China a more drug-friendly market
New guidelines to make China a more drug-friendly market
BioPharma Dive
China
CFDA
Flag link:
AstraZeneca’s Lung Cancer Drug Secures China Approval
AstraZeneca’s Lung Cancer Drug Secures China Approval
Investopedia
AstraZeneca
China
Tagrisso
non-small cell lung cancer
Flag link: